89 related articles for article (PubMed ID: 19808994)
1. Safe treatment of pulmonary hypertension with bosentan in a patient with moyamoya disease and cerebral ischemia.
Day RW; Brockmeyer DL; Feola GP
J Child Neurol; 2010 Apr; 25(4):504-7. PubMed ID: 19808994
[TBL] [Abstract][Full Text] [Related]
2. Bosentan - a previously unrecognised cause of facial telangiectasia.
Tong PL; Kumarasinghe SP
Ann Acad Med Singap; 2010 Nov; 39(11):874-5. PubMed ID: 21165531
[No Abstract] [Full Text] [Related]
3. Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution.
Montani D; Jaïs X; Dorfmuller P; Simonneau G; Sitbon O; Humbert M
Eur Respir J; 2009 Nov; 34(5):1204-6. PubMed ID: 19880623
[No Abstract] [Full Text] [Related]
4. An atypical presentation of liver enzyme elevation resulting from bosentan use.
Mulchey K; Bshouty Z
Can Respir J; 2009; 16(5):e54-6. PubMed ID: 19851530
[TBL] [Abstract][Full Text] [Related]
5. Graves' disease associated with primary systemic sclerosis.
Wimmersberger Y; Zuercher D
Orbit; 2009; 28(4):262-3. PubMed ID: 19839886
[TBL] [Abstract][Full Text] [Related]
6. Bosentan Inducing Autoimmune Hepatitis in a Patient with Idiopathic Pulmonary Arterial Hypertension.
de Araujo A; Mantovani A; Cerski CTS; Lopes AB; Bortoncello LC; Gazzana MB; Cheinquer H
J Gastrointestin Liver Dis; 2018 Mar; 27(1):89-92. PubMed ID: 29557420
[TBL] [Abstract][Full Text] [Related]
7. Hepatotoxicity by bosentan in a patient with portopulmonary hypertension: a case-report and review of the literature.
Eriksson C; Gustavsson A; Kronvall T; Tysk C
J Gastrointestin Liver Dis; 2011 Mar; 20(1):77-80. PubMed ID: 21451802
[TBL] [Abstract][Full Text] [Related]
8. Eisenmenger syndrome due to a large ductus arteriosus.
Labombarda F; Kerros H; Grollier G
Arch Cardiovasc Dis; 2010; 103(11-12):623-5. PubMed ID: 21147447
[No Abstract] [Full Text] [Related]
9. Eisenmenger's syndrome in pregnancy.
Correale M; D'Amato N; D'Agostino C; Di Biase M
J Cardiovasc Med (Hagerstown); 2013 May; 14(5):384-7. PubMed ID: 21135589
[No Abstract] [Full Text] [Related]
10. Pulmonary arterial hypertension: combination therapy in the modern management era.
Sitbon O
Eur Respir Rev; 2010 Dec; 19(118):348-9. PubMed ID: 21119195
[No Abstract] [Full Text] [Related]
11. Use of Bosentan in neonatal post cardiac surgery pulmonary hypertension.
Pawar R; Kasar P; Garekar S; Kulkarni S
Ann Pediatr Cardiol; 2009 Jul; 2(2):173-4. PubMed ID: 20808636
[TBL] [Abstract][Full Text] [Related]
12. Hereditary hemorrhagic telangiectasia: rare cause of pulmonary hypertension?
Providência R; Cachulo Mdo C; Costa GV; Silva J; Lemos CG; Leitão-Marques AM
Arq Bras Cardiol; 2010 Mar; 94(3):e34-6, e94-6. PubMed ID: 20730251
[TBL] [Abstract][Full Text] [Related]
13. Unilateral absence of a left pulmonary artery: successful therapeutic response to a combination of bosentan and warfarin.
Ghanbari H; Feldman D; David S; Saba S
Circ Cardiovasc Imaging; 2009 Nov; 2(6):e46-8. PubMed ID: 19920035
[No Abstract] [Full Text] [Related]
14. Sarcoidosis-induced pericarditis in a patient with portopulmonary hypertension: a case report.
Giouleme O; Anagnostis P; Patsiaoura K; Vasiliadis T; Grammatikos N; Kakavas N; Mpoumponaris A; Eugenidis N; Basayannis E
Cases J; 2009 Aug; 2():8640. PubMed ID: 19918393
[TBL] [Abstract][Full Text] [Related]
15. Bosentan-induced immune hemolytic anemia in 17 years old man. A case report.
Afra F; Mehri M; Namazi S
Daru; 2021 Jun; 29(1):211-215. PubMed ID: 33486694
[TBL] [Abstract][Full Text] [Related]
16. Successful bosentan therapy for pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia.
Chang SA; Jang SY; Ki CS; Kang IS; Kim DK
Heart Vessels; 2011 Mar; 26(2):231-4. PubMed ID: 21132305
[TBL] [Abstract][Full Text] [Related]
17. Sinus venosus atrial septal defect in a 31-year-old female patient: a case for surgical repair.
Gatzoulis MA; Giannakoulas G
Eur Respir Rev; 2010 Dec; 19(118):340-4. PubMed ID: 21119193
[TBL] [Abstract][Full Text] [Related]
18. A case of curable pulmonary hypertension.
Guérin P; Hoang P; Baron O
Arch Cardiovasc Dis; 2010; 103(8-9):489-90. PubMed ID: 21074129
[No Abstract] [Full Text] [Related]
19. The efficacy of tocilizumab in a patient with pulmonary arterial hypertension associated with Castleman's disease.
Arita Y; Sakata Y; Sudo T; Maeda T; Matsuoka K; Tamai K; Higuchi K; Shioyama W; Nakaoka Y; Kanakura Y; Yamauchi-Takihara K
Heart Vessels; 2010 Sep; 25(5):444-7. PubMed ID: 20676969
[TBL] [Abstract][Full Text] [Related]
20. Severe pulmonary hypertension in histiocytosis X: long-term improvement with bosentan.
Kiakouama L; Cottin V; Etienne-Mastroïanni B; Khouatra C; Humbert M; Cordier JF
Eur Respir J; 2010 Jul; 36(1):202-4. PubMed ID: 20595165
[No Abstract] [Full Text] [Related]
[Next] [New Search]
